SmurfVA's Random Picks

[Ned Serious]

No idea. I just figure its gotta be a lot higher then it is now. Here's a snippet of info from Bob Stock's seeking alpha article written last month:

Conclusion

Venaxis has a market cap of $50 million with a current price per share of $2.42. Therefore, I consider Venaxis to be a very promising company with great potential for price appreciation. I believe it warrants a price per share of $6 to $7 based on successful data results (in Q1/2014) and revenue projections. Canaccord Genuity gives APPY a $7.00 price target.

link: http://seekingalpha.com/article/1994961-biota-pharmaceuticals-inc-and-venaxis-inc-2-upcoming-biopharmaceuticals-catalysts-that-could-generate-big-gains

----------------

I'll be checking Bob's board to see his thoughts about the results coming up tomorrow. It seems to have had positive data all along from what I've read. Will probably hold 1/2 or all through tomorrow's news.